Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
8.80
+0.52 (6.28%)
At close: May 12, 2025, 4:00 PM
8.40
-0.40 (-4.55%)
Pre-market: May 13, 2025, 4:09 AM EDT
Arcus Biosciences Analyst Ratings
Total Analysts
11
Consensus Rating
Buy
Price Target
$25.33
Upside
+187.84%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $24 → $22 | Buy | Maintains | $24 → $22 | +150.00% | May 9, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $15 → $13 | Hold | Maintains | $15 → $13 | +47.73% | May 8, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $29 → $26 | Buy | Maintains | $29 → $26 | +195.45% | May 7, 2025 |
| Barclays | Barclays | Buy Maintains $29 → $14 | Buy | Maintains | $29 → $14 | +59.09% | Apr 23, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $24 | Hold → Strong Buy | Upgrades | $24 | +172.73% | Feb 26, 2025 |
| B of A Securities | B of A Securities | Hold Maintains $22 → $17 | Hold | Maintains | $22 → $17 | +93.18% | Feb 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $20 → $18 | Hold | Maintains | $20 → $18 | +104.55% | Feb 18, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $36 → $25 | Buy | Maintains | $36 → $25 | +184.09% | Feb 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $20 | Hold | Reiterates | $20 | +127.27% | Nov 6, 2024 |
| Barclays | Barclays | Buy Maintains $25 → $29 | Buy | Maintains | $25 → $29 | +229.55% | Oct 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $20 | Hold | Reiterates | $20 | +127.27% | Oct 24, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Initiates $20 | Hold | Initiates | $20 | +127.27% | Oct 21, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $29 | Buy | Initiates | $29 | +229.55% | Oct 8, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Oct 7, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Oct 3, 2024 |
| Wedbush | Wedbush | Buy Reiterates $30 | Buy | Reiterates | $30 | +240.91% | Oct 3, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.